Patient Adherence

Otsuka And Proteus® Announce The First U.S. FDA Approval Of A Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)

November 16, 2017

ABILIFY MYCITE (aripiprazole tablets with sensor) is a drug-device combination product comprised of Otsuka’s oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor. The ABILIFY MYCITE System includes: ABILIFY MYCITE, the MYCITE® Patch (wearable sensor); the MYCITE APP (a smartphone application); and web-based portals for healthcare providers and caregivers(1)  The system records medication […]

Michael Griffith Joins the HealthPrize Technologies Board of Directors

November 7, 2017

Former inVentiv executive brings key pharmaceutical services sector experience to HealthPrize’s board Norwalk, Conn. – November 6, 2017 – HealthPrize Technologies, a provider of adherence and patient engagement technology for the life sciences industry, announced today the appointment of Michael Griffith to its Board of Directors. Griffith is an operating partner of San Francisco-based private […]

Patient Centricity Works

October 18, 2017

Ensuring a patient-first strategy drives real results in commercial pharma Does patient centricity work? Actually, yes. There are increasing volumes of evidence that demonstrate that when you focus on the difference you make to patients, your commercial performance will improve. And, as other stakeholders adapt to the same economic conditions, driven by data and our ability to measure […]

Medisafe Launches Free Adherence Grader Tool That Ranks Adherence To Pharma Products Worldwide

October 5, 2017

BOSTON, Oct. 3, 2017 /PRNewswire/ — Medisafe, the leading medication adherence platform now surpassing 4 million global users, today announced the launch of Adherence Grader, a free data insights tool for the healthcare community interested in tracking medication adherence. Now available at AdherenceGrader.com, the tool gives pharmaceutical brands, researchers, caregivers, journalists and other interested parties […]

FDA Approves First Continuous Glucose Monitoring System For Adults Not Requiring Blood Sample Calibration

September 28, 2017

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip (often referred to as a “fingerstick”). The system reduces the need for fingerstick […]

How the Apple Watch Could Change How We Treat Heart Disease

September 13, 2017

The new Apple Watch Series 3 gives users more real-time information about their heart than ever, and Apple hopes that it will also be able to alert users to potentially concerning heart beat patterns. The current version of the Apple Watch already tracks heart rate. But the newest version comes with cellular built in, which […]

marcus evans to Host the 2nd Annual Innovation Excellence for Life Sciences Conference on November 29-30, 2017 in Boston, MA

September 5, 2017

marcus evans will host the 2nd Annual Innovation Excellence for Life Sciences Conference on November 29-30, 2017 in Boston, MA. By attending this exclusive event, delegates will receive practical knowledge and tangible insights from leading innovation, R&D, corporate development and strategic alliance professionals on how to institute internal frameworks that foster cross-lateral participation in innovation, […]

CR Expo China 2017 Poised to Boost Rise of Assistive Device Industry

August 21, 2017

The press conference for Care & Rehabilitation Expo China 2017 was held at China Disabled Persons’ Federation, on August 14th, 2017. Present at the conference are leaders including HU Xiangyang, Director of Rehabilitation Department of China Disabled Persons’ Federation, LI Xi, Director of China Assistive Devices and Technology Centre for Persons with Disabilities, OU Ling, […]

DDL to Exhibit at 7th edition PFS and Injectables Summit in San Diego

June 30, 2017

Recognizing the rapid developments in both technical and regulatory landscapes in injectable devices, the 7th edition PFS & Injectables Summit will return to San Diego with a growing audience and trending topics on September 25 – 27. With an increased focus on device quality and material safety, we are delighted to announce DDL’s joining as […]

Transparency and Authenticity is Key to a Successful Pharmaceutical Industry Collaboration with Patient Advocacy Groups

June 12, 2017

CHAPEL HILL, N.C., June 9, 2017 /PRNewswire/ — Pharmaceutical industry collaborations with patient advocacy groups are an important way for helping brands connect with patients throughout the product lifecycle.   In order to identify effective practices in patient advocacy group collaboration and relationship management, Best Practices, LLC undertook benchmarking research. This report examines the winning […]

Bayer Receives FDA Approval of myBETAapp and BETACONNECT Navigator

June 1, 2017

WHIPPANY, N.J., May 30, 2017 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for myBETAapp and the BETACONNECT Navigator. With this software in relapsing-remitting multiple sclerosis, people using the electronic BETACONNECT autoinjector to administer BETASERON (interferon beta-1b) can use Bluetooth technology to connect […]

Global Pharma Teams Likely to Increase Outsourced Patient Adherence Personnel

May 25, 2017

RESEARCH TRIANGLE PARK, NC–(Marketwired – May 24, 2017) – A new study found that surveyed global teams are more likely to change patient adherence staffing levels, with half of the teams expecting to increase their outsourced FTEs, according to business intelligence provider Cutting Edge Information. The data in Patient Adherence Program Planning: Drive Compliance to […]

India mandates bioequivalence studies, improving patient safety assurance for generics

May 8, 2017

With the Ministry of Health and Family Welfare making bioequivalence studies compulsory for all drugs on April 3rd this year, the focus on patient safety and efficacy has improved greatly. This mandate in addition to being an accurate tool to test the quality of generics has also come at a precise time with the debate […]

FEEDBACK